Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01759940
Other study ID # cervicalblock
Secondary ID 2012-002769-37
Status Completed
Phase Phase 4
First received December 31, 2012
Last updated March 15, 2014
Start date November 2012
Est. completion date December 2013

Study information

Verified date March 2014
Source Salzburger Landeskliniken
Contact n/a
Is FDA regulated No
Health authority Austria: Agency for Health and Food Safety
Study type Interventional

Clinical Trial Summary

Carotid endarterectomy is commonly performed under cervical plexus block. This is presumed to offer advantages over general anesthesia in terms of monitoring neurological function during cross-clamping of the carotid artery since, in conscious patients, speech, cerebration, and motor power provide early measures of inadequate cerebral perfusion. Some studies also claim lower shunting requirements, lower cardiovascular morbidity, and shorter hospital stay.

Traditionally, the common methods of cervical plexus block are termed 'deep' or 'superficial'. The deep block, as described by Moore or Winnie and colleagues, consists of identifying the transverse processes of upper cervical vertebrae C2 - C4 and injecting local anesthetic directly into the deep (prevertebral) cervical space. This may be achieved either as separate injections or as a single injection. The superficial block incorporates a variety of procedures. The simplest is a s.c. infiltration of local anesthetic along the posterior border of sternocleidomastoid muscle by either the surgeon or the anesthetist.

An 'intermediate' block is one where the injecting needle pierces the investing fascia of the neck, deep to the s.c. layer, but superficial to the deep cervical (prevertebral) fascia. It is also possible to use a 'combined block', consisting of a deep injection and a superficial or intermediate injection.

Practitioners may prefer one block to another, but no consensus exists on the efficacy of one block when compared with another. However, it has been suggested that complications of the technique are related to the deep injection and not the superficial (or intermediate) injection. These complications include intrathecal or intravascular injection, respiratory problems related to phrenic nerve paralysis, or local anaesthetic toxicity.

In this study the Influence of the concentration of the local anesthetic ropivacaine on the quality of the intermediate cervical plexus block for carotid endarterectomy will be evaluated. For this purpose two different concentrations of ropivacaine will be compared (3,75% vs 7,5%). The primary endpoint of the study will be the quantity of the additional needed local anesthetic to achieve adequate operative analgesia. Furthermore we will record the frequency of the most common side effects as well as the patient satisfaction with a standardized questionnaire.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date December 2013
Est. primary completion date September 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients scheduled for carotid endarterectomy in regional anesthesia

Exclusion Criteria:

- refusal to participate in the trail

- age < 18a

- gestation/breastfeeding

- contraindication for regional anesthesia

- inclusion in other trails

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Intermediate Cervical Plexus Block for Carotid Endarterectomy

Intervention

Drug:
ropivacaine 0,375%

ropivacaine 0,75%


Locations

Country Name City State
Austria Klinik für Anästhesiologie, perioperative Medizin und allgemeine Intensivmedizin Salzburg

Sponsors (1)

Lead Sponsor Collaborator
Salzburger Landeskliniken

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary amount of additional needed local anesthetics by the surgeon The surgeon will titrate the local anesthetic lidocaine 2%to achieve adequate operative analgesia for the patient. During the surgical procedure the patient will not be sedated therefore distinct communication to the patient is always possible. The primary endpoint will be evaluated continuously during the ongoing surgery by interrogating the patients pain scale every two to five minutes. In average the whole procedure will take 30 to 50 minutes. No
Secondary plasma concentrations of ropivacaine measured with mass spectrometry until 8h postoperative No
Secondary vital signs continuous recording of vital signs during the surgery as well as in the postoperative ICU whole day of surgery No
Secondary effect on the diaphragm function assessment of phrenic nerve paresis by ultrasound measurement of the diaphragm excursions, performed by the radiologist on call until 6 h postoperative No